AUS
NZ
UK
CA
USA
IND
Healt
EBOS Group Navigates Changing Pharmaceutical Landscape
October 23, 2024 05:14 PM AEDT| By Team Kalkine MediaHighlights,EBOS Group reports growth despite industry challenges.,Cann Group sees production gains, but financial pressures persist.,Atomo Diagnostics tackles rising syphilis cases with innovative testing.,EBOS Group (ASX:EBO), a major player in the...
4DMedical Receives $1.9 Million Grant to Expand Trials for Advanced Lung Imaging Technology
October 23, 2024 11:48 AM AEDT| By Team Kalkine MediaHighlights:,4DMedical Ltd (ASX:4DX) has secured $1.9 million from the Australian Federal Government to expand clinical trials for its,CT:VQ,lung imaging technology.,The,CT:VQ,technology enables the measurement of airflow and blood flow in the lungs w...
Aroa Biosurgery Sees Revenue Growth and Expands US Operations
October 22, 2024 04:26 PM AEDT| By Team Kalkine MediaHighlights,Aroa Biosurgery sees strong revenue growth and reduced cash outflow.,Key products like Myriad and,OviTex,continue to drive sales across multiple regions.,Regulatory approvals and clinical evidence bolster ARX's market position.,Aroa Biosur...
Life Sciences Sector Reports Mixed Results as Quarterly Updates Roll In
October 22, 2024 04:06 PM AEDT| By Team Kalkine MediaHighlights,Quarterly reports show mixed results for life sciences companies.,Next Science shares drop significantly after sales decline.,Aroa Biosurgery sees strong growth in sales.,As the end of October approaches, many companies in the life science...
Insights into CSL Share Price Movement Being Gathered in 2024
October 22, 2024 03:02 PM AEDT| By Team Kalkine MediaHighlights,CSL’s Share Price Growth:,CSL Ltd (ASX: CSL) has seen a 3.1% increase in share price since the start of 2024, reflecting its stable market performance.,Significant Recovery for Zip Co:,Zip Co Ltd (ASX: ZIP) has experienced a remarkable rec...
InhaleRx Shares Surge by 36% on Significant Funding Agreement Announcement
October 18, 2024 05:11 PM AEDT| By Team Kalkine MediaHighlights,The company has secured funding of up to $38.5 million from Clendon Biotech Capital.,Funding to support IRX-211 (for breakthrough cancer pain) and IRX-616a (for panic disorder).,Shares surged 36% following the announcement, reflecting stro...
Telix Pharmaceuticals Announces Proposed Nasdaq Listing
October 18, 2024 05:04 PM AEDT| By Team Kalkine MediaHighlights,Telix to list ADSs on Nasdaq under ticker,"TLX",.,Part of Telix's plan to broaden its global investor base and enhance its U.S. operations.,Telix will continue to be primarily listed on the ASX.,Shares of Telix Pharmaceuticals Limited (ASX...
Tryptamine Therapeutics Completes Phase 1b Trial for Psilocin Formulation TRP-8803
October 18, 2024 04:12 PM AEDT| By Team Kalkine MediaHighlights,Tryptamine Therapeutics completes safety evaluation of TRP-8803.,The trial showed positive safety results with IV-infused psilocin treatment.,The company now looks toward further clinical studies with Phase 2 trials.,Tryptamine Therapeutic...
Telix (ASX:TLX) Targets Sales Growth with New Cancer Treatments and US Listing
October 18, 2024 03:47 PM AEDT| By Team Kalkine MediaHighlights,Telix Pharmaceuticals plans to double sales with new cancer treatment products.,Illuccix sales expected to expand with upcoming regulatory approvals.,Nasdaq listing planned without raising new capital or issuing shares.,Telix Pharmaceutica...
Latin Resources Advances at Colina Lithium Project with Key Achievements
October 18, 2024 03:43 PM AEDT| By Team Kalkine MediaHighlights:,Latin Resources Limited is focused on advancing its Colina Lithium Project in Brazil, having defined a maiden mineral resource of 45.2 million tonnes at 1.32% lithium oxide.,A significant acquisition by Pilbara Minerals will see Latin Res...
InhaleRX Raises $38.5 Million from Clendon for Biotech Initiatives
October 18, 2024 03:22 PM AEDT| By Team Kalkine MediaHighlights:,InhaleRX initiates clinical trials for cannabis-based compounds aimed at pain management and mental health.,The company has secured significant funding from Victorian VC firm Clendon to support its research and development efforts.,Inhale...
Tryptamine Therapeutics Marks Safety Milestone in Psilocin IV Infusion Trials
October 18, 2024 11:58 AM AEDT| By Team Kalkine MediaHighlights,Tryptamine Therapeutics Ltd achieves safety milestone in psilocin IV infusion trial.,TRP-8803,deemed,safe after Phase 1b study involving 11 participants.,Further trials planned, with preparations for a Phase 2 study underway.,Tryptamine Th...
Telix Pharmaceuticals' Quarterly Revenue Exceeds AU$200M Mark
October 18, 2024 11:42 AM AEDT| By Team Kalkine MediaHighlights,Telix,Pharmaceuticals reports AU$201M in quarterly revenue,.,Sales growth driven by,prostate,cancer imaging product,,Illuccix,.,Company expects full-year revenue to reach between AU$745M to AU$776M.,Telix Pharmaceuticals,(ASX:TLX),has repo...
Vitura Health Limited's (ASX:VIT) Share Price Climbs, but Revenue Challenges Remain
October 18, 2024 11:05 AM AEDT| By Team Kalkine MediaHighlights,Vitura,Health Limited shows a significant rise in share price despite ongoing challenges.,Recent revenue performance and price-to-sales ratio,indicate,market skepticism.,Company’s medium-term growth contrasts with higher industry expectati...
Pro Medicus (ASX:PME) A Deep Dive into Financial Performance and Growth
October 17, 2024 06:40 PM AEDT| By Team Kalkine MediaHighlights,Pro Medicus reported significant profit growth with solid financial health.,The company’s radiology IT software and Visage platform play a key role in the healthcare sector.,PME has a strong return on equity and minimal debt, positioning i...
Frameworks for Valuing ASX and RMD Shares
October 17, 2024 03:57 PM AEDT| By Team Kalkine MediaHighlights:,ASX Limited has experienced a 4.9% increase in share price since the beginning of 2024, reflecting positive market sentiment.,ResMed CDI is currently trading approximately 66.9% above its 52-week low, indicating a potential recovery in s...
Six Critical Metrics Employed in PME Share Valuation
October 17, 2024 03:30 PM AEDT| By Team Kalkine MediaHighlights:,Pro Medicus Limited has experienced a remarkable share price increase of 97.13% in 2024, highlighting strong market performance.,The company reports impressive revenue and profit growth, with a compound annual growth rate (CAGR) of 33.4%...
Anteris Technologies Secures R&D Tax Refund for Medical Innovations
October 17, 2024 01:13 PM AEDT| By Team Kalkine MediaHighlights,Anteris Technologies receives a significant R&D tax refund.,The company focuses on advancing heart-related technologies.,Funding supports development and clinical trials for innovative devices.,Anteris Technologies Ltd,(ASX:AVR),has been a...
Five-Year Extension of $32 Million Contract for RIS Technology Awarded to Pro Medicus
October 16, 2024 10:59 PM AEDT| By Team Kalkine MediaHighlights:,Contract Extension:,Pro Medicus Ltd has secured a five-year contract extension valued at a minimum of $32 million with a prominent Australian Radiology Network.,Technological Leadership:,The contract pertains to PME’s Radiology Informatio...
PME and BHP Share Prices Acknowledged as Noteworthy
October 16, 2024 10:27 PM AEDT| By Team Kalkine MediaHighlights:,Pro Medicus Growth:,Pro Medicus Limited (ASX: PME) has experienced a notable 93% increase in its share price since the start of 2024, reflecting strong market confidence.,BHP’s Stability:,BHP Group Ltd (ASX: BHP) is currently 14.4% below...
Advertise your brand on Kalkine Media